Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed, along with the need for diversification. Cramer highlighted that he is fond of the stock, as he said: “You could own JNJ and Merck with their incredible franchises. You know what? I’m actually particularly fond of JNJ right now. They’re spinning off their commoditized artificial joint business.” Photo by Adam Nowakowski on Unsplash Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products, including pharmaceuticals and m ...

Johnson & Johnson (JNJ) is a global healthcare conglomerate, renowned for its broad presence in pharmaceuticals and medical devices. Headquartered in New Brunswick, New Jersey, its market cap is around $500.1 billion. Johnson & Johnson has evolved into one of the world’s largest and most diversified healthcare firms, with a global workforce and a portfolio spanning cutting-edge therapeutics, medical technologies, and historically, consumer health brands. Companies worth $200 billion or more are generally ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company†or "Covalon†) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on November 18, 2025 of its first ever dividend – a special cash dividend of C$0.15 per common share – reflecting the Company's strong financial performance and continued success in accelerating the adoption of its unique, patented, life-saving and life-improving medical technologies. This special dividend. ...